title: Efficacy of low dose prednisone plus aspirin in preventing spontaneous abortions and/or fetal deaths due to antiphospholipid antibodies: results of a pilot study.
authors.forename: M G
authors.initials: MG
authors.lastname: Mazzucconi
authors.forename: F
authors.initials: F
authors.lastname: Dragoni
authors.forename: A
authors.initials: A
authors.lastname: Chistolini
authors.forename: M
authors.initials: M
authors.lastname: Peraino
authors.forename: R
authors.initials: R
authors.lastname: Paesano
authors.forename: M
authors.initials: M
authors.lastname: Di Prima
authors.forename: F
authors.initials: F
authors.lastname: Di Francesco
authors.forename: C
authors.initials: C
authors.lastname: Masala
authors.forename: A
authors.initials: A
authors.lastname: Pachì
mesh_terms: D000022:Abortion, Spontaneous / Q000517:prevention & control*; D000328:Adult; D017152:Antibodies, Antiphospholipid / Q000009:adverse effects*; D001241:Aspirin / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005260:Female; D005313:Fetal Death / Q000517:prevention & control*; D006801:Humans; D010865:Pilot Projects; D011241:Prednisone / Q000627:therapeutic use*; D011247:Pregnancy
chemical_list: D017152:Antibodies, Antiphospholipid; D004338:Drug Combinations; D001241:Aspirin; D011241:Prednisone